Updated:
Alpine BioVentures
Alpine BioVentures creates great companies with revolutionary science enabling patients to have better lives. The firm brings a unique perspective and actively...
Alpine BioVentures
Alpine BioVentures creates great companies with revolutionary science enabling patients to have better lives. The firm brings a unique perspective and actively nurtures strong relationships with scientific inventors to create and grow game-changing companies. It licenses innovative technologies and works with scientific inventors, and invests in scientific ideas so bold they make typical investors uncomfortable.
General information
Firm type
Venture Capital
Year founded
2013
Location
Region
North America
Country
United States
City
Seattle
Corporate office
Seattle, WA, United States
Principals
Mitchell H. Gold
MD — Founder & Managing Partner
Jay Venkatesan
MD — Managing Partner
David D. Miller — Principal
Remy Durand
PhD — Principal
Sector focus
Frequently asked questions
Which sectors fall within Alpine BioVentures' mandate?
The firm focuses exclusively on life sciences, targeting genetic medicine, computational drug discovery, therapeutic delivery platforms, and digital health tools that accelerate preclinical development. Alpine BioVentures sources from university ecosystems and research hospitals, prioritizing interventions with defined mechanistic hypotheses and a patent-protected path to clinical translation.
Does Alpine BioVentures co-invest alongside other venture or private equity firms?
Given its seed-stage focus, Alpine BioVentures frequently constitutes the first institutional capital into a company, often before larger venture firms or crossover funds engage. The firm's posture is that of a lead or co-lead investor negotiating initial terms, though specific co-investor relationships and syndication partners are not systematically disclosed in public records.
What is the geographic focus of Alpine BioVentures?
Alpine BioVentures deploys capital across North American biotechnology hubs, with an emphasis on companies emerging from major research universities and affiliated medical centers. While headquarters are in Seattle, the firm's sourcing network spans the Boston-Cambridge corridor, the San Francisco Bay Area, and other dense academic research environments.
Profile maintained by Altss using OSINT (open-source intelligence), regulatory filings, licensed data partners, and verified direct submissions. Read the methodology. Last updated: . Continuous refresh with full update cycles at least every 30 days.
Need institutional-grade insight on venture capital firms?
Altss delivers:
Prefer a guided tour?
We’ll walk you through: